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Achieving Microparticles with Cell-Instructive Surface 
Chemistry by Using Tunable Co-Polymer Surfactants
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A flow-focusing microfluidic device is used to produce functionalized mono-
disperse polymer particles with surface chemistries designed to control 
bacterial biofilm formation. This is achieved by using molecularly designed 
bespoke surfactants synthesized via catalytic chain transfer polymerization. 
This novel approach of using polymeric surfactants, often called surfmers, 
containing a biofunctional moiety contrasts with the more commonly 
employed emulsion methods. Typically, the surface chemistry of micropar-
ticles are dominated by unwanted surfactants that dilute/mask the desired 
surface response. Time of flight secondary ion mass spectrometry (ToF-SIMS) 
analysis of particles demonstrates that the comb-graft surfactant is located 
on the particle surface. Biofilm experiments show how specifically engineered 
surface chemistries, generated by the surfactants, successfully modulate bac-
terial attachment to both polymer films, and microparticles. Thus, this paper 
outlines how the use of designed polymeric surfactants and droplet microflu-
idics can exert control over both the surface chemistry and size distribution of 
microparticle materials, demonstrating their critical importance for control-
ling surface-cell response.
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materials for a wide variety of different 
applications, such as reducing bacterial 
biofilm formation on medical devices, 
maintaining stem cell pluripotency, and 
providing bio-instructive implant mate-
rials.[2,4–7] Recent methodological develop-
ments have facilitated the screening of a 
library of (meth)acrylate copolymers to 
identify a “hit” material that prevented 
biofilm formation by diverse bacte-
rial pathogens including Pseudomonas 
aeruginosa, Staphylococcus aureus, 
and Escherichia coli.[5,8–10] The HT 
screening method used was based on 
polymer microarrays and has demon-
strated utility for the discovery of bioma-
terials that have been used as coatings 
on existing medical devices.[5,10] However, 
most therapeutic delivery systems are not 
delivered as coatings, rather they exhibit 
3D shapes. Thus, before these new bio-
materials can be regarded as potential can-
didates from which to fabricate medical 
devices/therapeutic delivery systems, the performance of these 
copolymers needed to be demonstrated on microparticles to 
show, for example, that biofilm formation can be controlled in 
a 3D environment. This is particularly important as topography 
influences eukaryotic cell and bacterial surface attachment.[11–13] 
As a consequence, it is important to move from the design of 
2D to 3D structures in order to gain a deeper understanding 
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/adfm.202001821.
1. Introduction
In the last decade, the use of combinatorial chemistry and 
high-throughput (HT) screening methods have delivered 
step-change improvements in the identification and design 
of new tailored materials.[1–4] In the specific field of biomate-
rials discovery, HT methods led to the development of bespoke 
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of the interaction of cells with their immediate extracellular 
environment and, consequently, derive more realistic biological 
models/assays that mimic real-life conditions.[14] Polymeric 
microparticles are a simple 3D structure that have numerous 
healthcare applications including tissue engineering, diagnos-
tics, and drug delivery.[15,16] However, a common problem with 
the production of particles, regardless of production technique, 
is the inclusion of unwanted surfactants which cover the surface 
of particles and are very difficult to remove.[16,17] This presents 
a problem for biomaterials, as numerous studies have shown 
that biological-surface interactions are dependent on surface 
chemistry.[13,16,18,19] For example, the presence of residual sur-
factant, such as the commonly used poly(vinyl alcohol-co-vinyl 
acetate) (PVA), has been shown to mask surface chemistry and 
impact on the resultant bacterial attachment properties[16] Thus, 
new approaches are required to produce particles which exhibit 
diverse surface chemistries where the process of preparation 
does not interfere with surface chemistry.
In this paper, a new strategy for the synthesis of microparti-
cles with specifically selected surface functionality is reported. 
This consists of the production of bespoke polymer surfmers, 
that is, amphiphilic surfactants, which possess 3D comb-graft 
molecular structures. These surfactants are synthesized using 
monomeric materials that are known to reduce or increase bac-
terial biofilm formation.[9,10] Monodisperse particle populations 
were then produced by using droplet-based microfluidics where 
emulsions were stabilized with the synthesized surfactants 
(Figure 1).
This approach demonstrated that, these surfactants not 
only aid droplet stabilization but also form an “active”, surface 
located, cell interactive layer because they become entrapped 
within particle macrostructures as they polymerize. To produce 
surfactants with  controlled molecular weight down to the oli-
gomer level and retain the integrity of chemical functionalities 
in the polymeric backbone, the efficient, robust and easy scal-
able catalytic chain transfer polymerization (CCTP) was used as 
the main polymerization strategy.[20,21] Avoiding the addition of 
new hetero-functionalities on the polymeric backbone should 
minimize any undesirable biological consequences from the 
presence of the surfactant on the particle surface.[22] The sur-
face chemistry of the resultant particles was assessed using 
time of flight secondary ion mass spectrometry (ToF-SIMS),[3] 
which demonstrated that the monodisperse polymer particles 
had been successfully surface functionalized with the desired 
chemical moieties. In subsequent biological assessment of 
these particles via incubation with P. aeruginosa, it was shown 
that the polymer microparticles facilitated the desired biological 
responses in a manner dependent on the surface chemistry of 
the particles. This response was independent of the materials 
used to construct particle cores, so correlating with pro- and 
anti-attachment 2D polymer films.
2. Results and Discussion
By investigating the attachment of P. aeruginosa to a wide 
library of polymers, presented in a microarray format, Sanni 
et  al. found that there was no relationship with water contact 
angle, but those found to resist biofilm formation were rela-
tively hydrophobic at 80–90 degrees.[5,8,9,23] To form a surfactant, 
we therefore require a hydrophilic partner for these mono-
mers. Contact printing was used to produce a polymer micro-
array screen in order to determine the levels of hydrophilic 
monomer content that could be introduced into a surfactant 
composition, whilst retaining the desired level of biological 
performance. Polymer microarrays consisting of 164 co- 
polymer spots were produced with two groups of monomers, one 
hydrophobic, and one hydrophilic. The array consisted of two 
different datasets with the first containing two hydrophobic 
major monomer components with the ability to either pre-
vent (ethylene glycol dicyclopentenyl ether acrylate (EGDPEA)) 
or support (2-hydroxy-3-phenyoxypropyl acrylate (HPhOPA)) 
biofilm development (Figure  2a). These two monomers were 
combined with one of the five variable chain length hydrophilic 
“minor” monomers made from either poly(ethylene glycol) 
methyl ether methacrylate (mPEGMA) or poly(ethylene glycol) 
methacrylate (PEGMA) (PEGMA360, PEGMA500, mPEGMA300, 
mPEGMA500, and mPEGMA164 (also known as diethylene 
glycol methyl ether methacrylate)) (Figure 2a). Monomers from 
the two groups were combined in v:v (hydrophobic:hydrophilic) 
ratios of 0:100, 50:50, 60:40, 70:30, 75:25, 80:20, 85:15, 90:10, 
and 100:0. A second set of materials investigated the effect of 
specific hydrophilic monomer (mPEGMA300) concentrations 
on a range of other biologically active, hydrophobic monomers. 
In this set, one of ten monomers (phenyl acrylate (PhA), phenyl 
methacrylate (PhMA), butyl acrylate (BuA), ethyl acrylate (EA), 
furfuryl methacrylate (FuMA), isobutyl acrylate (iBuA), lauryl 
acrylate (LaA), tetrahydrofurfuryl acrylate (THFuA), isobornyl 
methacrylate (IBMA), and 2-N-morpholinoethyl methacrylate 
(NMEMA) were combined pairwise with mPEGMA300. These 
materials were combined in v:v (hydrophobic:mPEGMA300) 
ratios of 0:100, 50:50, 60:40, 70:30, 75:25, 80:20, 85:15, 90:10, 
and 100:0. mPEGMA164 was included as a comparison as 
Figure 1. Schematic illustrating the use of polymer microarrays to identify 
the molecular composition of bespoke polymer surfactants and the sub-
sequent synthesis of surfmers. The surfmers were then used in a flow-
focusing microfluidic chip to produce surface-functionalized polymer 
microparticles. The particles were then incubated with P. aeruginosa to 
determine the impact of the microparticle surface on bacterial attachment 
and subsequent biofilm formation.
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Figure 2. a) Structures of the monomers used for printing polymer microarrays showing major hydrophobic monomers in the blue panel and the minor 
hydrophilic monomers in the red panel. Chain lengths were either n = 6 or 9/10 for PEGMA monomers or m = 2, 4/5 or 9/10 for mPEGMA b) results from 
polymer microarray with mCherry tagged P. aeruginosa. Monomer identity is organized into rows and mixing ratio into columns. The center square is the 
fluorescence value for P. aeruginosa attachment (red indicates high biofilm attachment and white indicates low biofilm attachment), while the narrow 
columns to the left or right indicate ± 1 standard deviation. Data is shown from n = 6, N = 2 repeats. c) Copolymer data for EGDPEA with a range of dif-
ferent PEG-based hydrophilic chains, showing attachment of P. aeruginosa across a sequential copolymer series n = 6, N = 2 and d) copolymer data for 
HPhOPA with a range of different PEG-based hydrophilic chains, showing attachment of P. aeruginosa across a sequential copolymer series n = 6, N = 2.
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previously published work showed that copolymers made with 
five hydrophobic, (meth)acrylate monomers copolymerized 
with mPEGMA164 in mol%:mol% ratio of up to 75:25 could be 
used as a coating material that retained attachment inhibitory 
properties at levels comparable with the original homopol-
ymer.[22] Figure  2a,b contain the molecular structures of all 
monomers used in the study and the HT biological assays of 
the copolymer spots.
For all copolymer series investigated, the average bacte-
rial attachment deviated from the hydrophobic homopolymer 
fluorescence value with increasing PEGMA/mPEGMA con-
centrations in the copolymer (Figure  2c,d). This suggested 
that the introduction of these hydrophilic co-monomers 
compromised the biological performance. These results are 
consistent with the findings upon addition of DEGMA by 
Adlington et  al.[22] Biofilm resistance of weakly amphiphilic 
(meth)acrylates has been correlated with the hydrophobicity 
and molecular stiffness of the resultant polymers.[8,9] Dilution 
of these monomers with PEGMA/mPEGMA is therefore 
consistent with the increased biofilm formation. When the 
hydrophilic component is increased beyond a v:v ratio of 
90:10, the attachment of P. aeruginosa was significantly higher 
than that of the homopolymer for EGDPEA. However, the 
EGDPEA-co-mPEGMA300 copolymer series exhibited attach-
ment levels that were more consistent with the EGDPEA 
homopolymer and stayed at within approximately 90% per-
formance up to a v:v ratio of 85:15. Therefore, it was con-
cluded that a hydrophilic chain length of up to 4–5 ethylene 
glycol units when capped with a methoxy terminal group 
does not dramatically alter the attachment of P. aeruginosa 
up to a ratio of 85:15. Changes in the bacterial attachment 
were also observed for the HPhOPA copolymer series con-
taining PEGMA360, PEGMA500, and mPEGMA500 compared to 
the HPhOPA homopolymer. However, the copolymer series 
including mPEGMA164 and mPEGMA300 exhibited attach-
ment levels comparable with the HPhOPA homopolymer. 
This comparison was also noted in the EGDPEA-co-mPEGMA 
data suggesting that mPEGMA164 and mPEGMA300 have 
not located to the surface, allowing the hit material proper-
ties to dominate. Therefore, the v:v ratio 90:10 was selected 
as the optimum ratio for the surfactant molecular design, 
as this ratio retained the biological properties of the original 
homopolymer. Other examples of different copolymers were 
also included with mPEGMA300 only, and these can be found 
in (Figure S1, Supporting Information).
2.1. Surfactant Synthesis
To synthesize polymeric surfactants which exhibit the target 
ratio of 90:10 (v:v), the reaction conditions in terms of catalyst 
concentration (850 ppm) and solvent:co-monomer ratio (3:1 v:v) 
were maintained constant throughout the polymerizations. The 
bis[(difluoroboryl)diphenylglyoximato]cobalt(II) (PhCoBF) con-
centration has been optimized in order to produce materials 
with Mn’s in the range of 15–25 kDa. This Mn range was chosen 
in order to maintain the viscosity of copolymer solutions used 
in the microfluidics apparatus within the operating parameters 
of the equipment. Meanwhile, the 3:1 solvent ratio was selected 
based on a previous study on EGDPEA:mPEGMA164 copolym-
erization, where this ratio was found to deliver the best results 
for achieving the target co-monomer ratio, controlling Mn, and 
polydispersity.[22] However, for HPhOPA based surfactants, a 
higher solvent:co-monomer ratio (5:1 (v/v)) was used because 
of the high viscosity exhibited by the starting materials. The 
percentage conversions and the molecular weights of the copol-
ymer library generated in this study are shown in Table 1.
The data in Table 1 shows that all the Mn’s are in the target 
range except EGDPEA-co-PEGMA500 (Table  1 entry 2) which 
exhibited higher Mn and Ð (304  kDa and 3.50). It was also 
observed that EGDPEA-co-PEGMA360 (Table  1 entry 1) exhib-
ited a significantly higher Ð and lower conversion than the 
mPEGMA300 copolymer (Table  1 entry 3). This was attributed 
to a negative interaction between the CCTP catalyst and the 
hydroxy end-group of PEGMA. The presence of electronic 
substituents, such as free OH or free amino groups, in the 
monomer structure can inhibit the catalytic activity by not 
allowing the release of the cobalt complex from the transi-
tion state, as Biasutti et al. have demonstrated.[24] In particular, 
when mPEGMA (300 and 500  Da) was used as the hydro-
philic counterpart, improvements were observed, in both of 
the copolymers, with either higher conversion or achieving 
the target Mn with a smaller polydispersity (aligned with Free 
Radical Polymerisation values). The copolymer bearing the 
methoxy equivalent of PEGMA360 (mPEGMA300), (Table  1 
entry 3), showed a conversion more than double (43%) that 
of the 20% of EGDPEA-co-PEGMA360 as well as a reduc-
tion in Mn and Ð. Despite the similar conversion between 
EGDPEA-co-mPEGMA500 and EGDPEA-co-PEGMA500, the 
EGDPEA-co-mPEGMA500 result confirmed the greater compat-
ibility of mPEGMA with the CCTP mechanism as the products 
exhibited a decreasing of the Mn, from 304 to 20 kDa. This was 
Table 1. Percentage conversions and calculated ratios for synthesized polymer surfactants showing a range of different hydrophilic chains (PEGMA360, 
PEGMA500, mPEGMA300, and mPEGMA500) and also different major co-monomer materials (EGDPEA + HPhOPA).
Entry Monomers Conversiona) [%] Feed ratio [%:%] Actual co-monomer ratioa) [%:%] Mnb) Ðb)
1 EGDPEA: PEGMA360 20 90:10 74:26 24.60 2.90
2 EGDPEA: PEGMA500 50 90:10 84:16 304.00 3.50
3 EGDPEA: mPEGMA300 43 90:10 87:13 16.00 1.69
4 EGDPEA: mPEGMA500 55 90:10 80:20 20.60 1.90
5 HPhOPA: mPEGMA300 80 90:10 88:12 26.89 1.86
6 HPhOPA 70 100:0 - 70.00 1.76
a)Conversion and actual co-monomer ratio were calculated using 1H-NMR data (Figures S2, S3, and S4, Supporting Information); b)Mn and Ð were calculated by GPC.
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also confirmed through a reduction in polydispersity from 
3.5 to 1.9. Therefore, the presence of a methoxy end-group on the 
side chain of the hydrophilic PEG-based co-monomer resulted 
in greater control. For HPhOPA, the conversion achieved was 
≈80% and the Mn was slightly higher than the targeted range 
(26.89  kDa). The higher Mn obtained, compared to the target 
of 20 kDa or below, was attributed to the presence of a hydroxy 
group in the HPhOPA side chain which may interfere with 
the catalyst action, a conclusion supported by the much higher 
Mn achieved for the CCTP-produced HPhOPA homopolymer 
(Table 1, Entry 6) . However, it was hypothesized that this OH 
group will not be as available to interact with the catalyst as 
in the case of PEGMA, due to the presence of a bulky phenyl 
group which will give the pendant group a rigid conformation 
and so restricted flexibility.
The co-monomer ratio achieved within the polymer back-
bone was determined by 1H-NMR analysis of the purified 
copolymers. The results in Table 1 show that the final monomer 
composition of all the surfactants was close to the target feed 
mol:mol ratio of 90:10 and within a range from 80:20 to 88:12. 
These results showed that the mPEGMA300 co-polymer gave 
ratios that were closer to the target value of 90:10 determined 
by the polymer microarray screening results compared to the 
mPEGMA500 alternative. Thus, this synthetic route successfully 
generated polymeric surfactants with chemical composi-
tions similar to those used for the 2D screen for the bacterial 
attachment. It also highlighted the use of mPEGMA300 for the 
on-going surfactant design to provide an optimal biological 
response because it delivers copolymers of target structure, a 
higher conversion compared with the PEGMA copolymers 
and gives the target value of copolymer ratios. This synthesis 
could be developed further through high throughput methods 
to manufacture many functionalized surfactants with the 
mPEGMA300 comonomer.[25]
2.2. Microparticle Production
To determine the suitability of mPEGMA300 based surfactants 
for microfluidic production of microparticles, the polymers 
were used as surfactants in an oil-in-water (O/W) droplet flow-
focusing system. The dispersed phase which was fed into 
the center channel consisted of 97% 1,6 hexanediol diacrylate 
(HMDA) as the particle “core” material, 2% (w:v) polymer sur-
factant and 1% (w:v) photoinitiator (2,2-Dimethoxy-2-phenylace-
tophenone (DMPA)). The continuous phase used was distilled 
water, which was fed into two side channels located perpen-
dicular to the central feed. The emulsion droplets formed by 
impinging these two phases were collected in a receiver flask 
where they were irradiated with a 365  nm fiber optic UV 
source to form solid polymer microparticles. The flow of both 
the continuous and dispersed phase was optimized to ensure 
that particles were produced, whilst reducing the risk of wall-
wetting events, jetting behavior and unstable particle forma-
tion. Figure 3 shows the flow diagram of the system using the 
EGDPEA-co-mPEGMA300 surfmer.
As shown in Figure  3, the EGPDEA-co-mPEGMA300 
surfactant was sufficiently amphiphilic to produce stable 
emulsions. As the flow rates of both the continuous (Qc) and 
dispersed phases (Qd) increased, the system started to display 
jetting behavior, while an increase in Qc alone resulted in the 
appearance of satellite droplets. However, if the dispersed flow 
rate is not large enough, the size of the emulsions formed begins 
to increase and this leads to wall-wetting events. Therefore, the 
conditions of Qc = 5 mL h−1 and Qd = 0.2 mL h−1 were chosen as 
flow rates that would ensure the long-term stability of emulsion 
production within the microfluidics system whilst maximizing 
particle output. The effect of the PEGMA/mPEGMA chain 
length on the emulsion/particle stability was investigated, and 
SEM images in Figure S5, Supporting Information show that 
Figure 3. Flow diagram of an oil-in-water microfluidics system with HMDA core material and EGDPDEA-co-mPEGMA300. O denotes idealistic dripping 
behavior, X denotes jetting behavior, ϒ denotes formation of satellite droplets, and Δ denotes flow rates which caused wall wetting events. Blue denotes 
region of flow rates that produces monodisperse emulsions, red denotes areas of no emulsion formation, and orange denotes area which produces 
variable emulsion sizes. Images show examples of dripping, jetting, satellite droplet formation, and wall wetting events respectively.
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there was little effect on the particle polydispersity. Therefore, 
the hydrophilic component mPEGMA300 was selected as the 
co-monomer for the rest of the study based on the conclusions 
derived from the synthesis and manufacturing data, as well as 
from the 2D biological screening assay.
Prior to collecting particles with the HPhOPA-co-mPEGMA300 
surfactant, a flow diagram was constructed (Figure S6, Sup-
porting Information). Particles were produced using the 
HPhOPA-co-mPEGMA300 polymer to observe whether mono-
disperse particles could be produced with surfactants made 
from different monomers. A 1:1 wt:wt ratio of EGDPEA-co-
mPEGMA300 and HPhOPA-co-mPEGMA300 was also used to 
determine whether the polymer surfactant could be blended 
to create stable particles with a cofunctionalized surface. The 
microfluidics particle sizing data obtained are shown in Figure 4.
The production of polymer microparticles using droplet 
microfluidics generated monodisperse particle populations 
with individual surfactants (Figure  4a–c). When no surfactant 
was added, the HMDA core monomer was sufficiently amphi-
philic to be able to produce polymer microparticles, but with 
a much broader size distribution (CV = 15.9%). Additionally, 
Figure  4b shows that it is possible to produce particles when 
incorporating two different surfactants within the production 
method, where both EGDPEA-co-mPEGMA300 and HPhOPA-co-
mPEGMA300 were used at a ratio of 1:1 wt:wt and an overall 2% 
wt:wt surfactant concentration. However, the size distribution 
was slightly larger (CV = 8.4%) when compared to that obtained 
using EGDPEA-co-mPEGMA300 or HPhOPA-co-mPEGMA300 
alone (CV = 2.1 and 2.7% respectively). This process could be 
particularly useful when wanting to cofunctionalize particles 
with different biological properties for an application such as 
wound healing where it is desirable to promote an appropriate 
immune response whilst preventing bacterial biofilm formation.
2.3. Microparticle Surface Characterization
Time of flight secondary ion mass spectrometry (ToF-SIMS) 
analysis was conducted to investigate the surface chemistry of 
the microparticles produced. Data was collected in both positive 
and negative secondary ion mode in order to determine unique 
ions associated with the polymer surfactants. Unique identifiers 
for EGDPEA (C5H7+), HPhOPA (C6H5O−), and mPEGMA300 
(C3H7O+) were identified for each surfactant. No character-
istic peak could be identified for the HMDA core polymer. 
However, particles prepared with surfactant were compared 
with the HMDA core particles prepared without surfactant, 
shown in Figure 4e, to demonstrate the difference between the 
unfunctionalized and functionalized particles. Flat controls of 
both EGDPEA-co-mPEGMA300 and HPhOPA-co-mPEGMA300 
were used to highlight any molecular level differences in the 
surface conformations introduced by moving from flat to par-
ticle surfaces (Figure 5).
Microparticles made with only EGDPEA-co-mPEGMA300 
or HPhOPA-co-mPEGMA300 only generated one unique ions 
(C5H7+ or C6H5O−) to show the presence of either EGDPEA 
or HPhOPA on the particle surface. Comparison of the parti-
cles with the plain core HMDA particles clearly demonstrated 
that the ions were unique to the two individual surfactants and 
therefore showed that the surfactant is located at the surface of 
Figure 4. SEM images of polymer microparticles produced using a microfluidic droplet approach. (i) size of particles shown in images A–E. A) Mono-
disperse particles made with EGDPEA-co-mPEGMA300 surfactant with a core made from HMDA and a size of 64.30 ± 1.33 µm (CV = 2.1%). B) Particles 
made with EGDPEA-co-mPEGMA300 and HPhOPA-co-mPEGMA300 in a 1:1 ratio with a core made from HMDA and a size of 62.2 ± 5.2 µm (CV = 8.4%). 
C) Particles produced with HPhOPA-co-mPEGMA300 with a core made from HMDA with a size of 62.42 ± 1.66 µm (CV = 2.7%). D) Particles made with 
PVA surfactant with a core made from HMDA with a size of 61.60 ± 2.93 µm (CV = 4.8%). E) Particles made with only HMDA core material with no 
surfactant with a size of 73.09 ± 11.63 µm (CV = 15.9%).
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the particles. This process ensured that the surface was func-
tionalized with the biologically active material of choice. By 
using both surfactants in a microparticle batch production it 
was also possible to show that both C5H7+ and C6H5O− ions are 
present on the particle surface, indicating that surfaces with 
mixed surfactants had been successful produced. The ion indic-
ative of the mPEGMA chain (C3H7O+) can also be found at the 
surface of the functionalized particles. However, the intensity 
for this ion is reduced on the HMDA core particle with no sur-
factant, which is to be expected as there is no mPEGMA on the 
sample and therefore a reduced C3H7O+ intensity. These results 
establish the concept that, by using bespoke functionalized 
surfactants, polymer microparticles can be manufactured with 
specific targeted surface chemistry functionalization. Therefore, 
such particles should allow for specific surface chemistry struc-
tures to be tested on a 3D scale that was not previously possible.
2.4. Cell Cytotoxicity and Bacterial Attachment to Polymer 
Microparticles
Only trace amounts of monomer were detected using an NMR 
extraction process in chloroform (Figure S7, Supporting Infor-
mation). To ensure that cells remain viable during particle 
exposure, cytotoxicity tests with MRC-5 (ATCC CCL171) human 
lung fibroblasts were performed and showed no cytotoxicity 
up to 5  mg mL−1 (Figure S8, Supporting Information). This 
demon strated that any small traces of monomer did not affect 
the cell viability. To observe whether the surfactant surface 
chemistry had an effect on biological performance, particles 
were cultured with fluorescently labelled P. aeruginosa in RPMI 
medium for 24 h. Data was acquired using confocal microscopy 
to measure fluorescence. The analysis of attachment/biofilm 
levels was performed using a computer script that discarded 
any background fluorescence and only measured fluorescence 
associated with the particles by using both the brightfield and 
fluorescence images. The data was normalized for surface area 
and to the non-surfactant HMDA control for comparative pur-
poses (Figure 6).
The variation in biological performance related to modifying 
the surface chemistry via the choice of surfactant used is exem-
plified in the data presented in Figure 6. This figure shows how 
the expected HPhOPA-based surfactant exhibited an increase 
in biofilm formation compared with the EGDPEA and no sur-
factant (HMDA) control samples (2.2 and 1.3-fold respectively). 
In order to confirm that the variation in biological performance 
of 3D particles could be attributed directly to the surface chem-
istry, rather than the 3D topography of the particles, a series of 
2D films of the homopolymers of EGDPEA and HPhOPA were 
prepared and a P. aeruginosa attachment/biofilm assay was car-
ried out (Figures S9–10, Supporting Information). These results 
show how (meth)acrylate polymers modify the behavior of bac-
teria on surfaces; both on individual particle surfaces as well 
as a coating as previously demonstrated.[10,22] This also provides 
evidence that these (meth)acrylate polymers, when incorporated 
into surfactants, can be used to functionalize surfaces with a 
unimolecular coating, which would be impossible with the 
original homopolymer. It also extends the utility of polymers 
Figure 5. ToF-SIMS data showing intensities of 3 key ions associated with 3 monomers within the surfactant structures (C5H7+ – EGDPEA, C6H5O− – 
HPhOPA and C3H7O+ – mPEGMA) where the ions from the structures are circled in red, blue, and purple respectively. Samples (from left to right) 
include: 2D EGDPEA-co-mPEGMA300 sample spun cast onto silicon wafer, microparticles made using EGDPEA-co-mPEGMA300 surfactant, micropar-
ticles made using both EGDPEA-co-mPEGMA300 and HPhOPA-co-mPEGMA300 polymer surfactant, particles made from HPhOPA-co-mPEGMA300 
polymer surfactant, a 2D HPhOPA-co-mPEGMA300 sample spun cast onto silicon wafer and microparticles made using no surfactant and only the core 
material HMDA. Ion images for C6H5O− and C5H7+ below the graph correspond directly to the samples on the graph.
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discovered through the polymer microarray platform beyond 
currently used dip-coating applications.[26] This will therefore 
enable the targeting of further biofilm prevention applications 
where a dip-coating procedure would be inappropriate, such as 
for preventing infections in wounds where particles would offer 
a better packing density. This method of delivery would also 
have potentially lower associated costs by reducing the quantity 
of expensive bioactive polymers as consequence of only using 
minimal material (2%) as a surfactant in a microfluidic setup. 
PVA was also shown to prevent biofilm formation on the sur-
face effectively, and this corresponds with previous litera-
ture.[16,27] This data demonstrates the dependence of biological 
performance on the surface chemistry of the 3D particles and 
therefore the importance of controlling surface chemistry by 
using specific comb-graft surfactants.
3. Conclusion
In conclusion, this work has demonstrated that functionalized 
comb-graft surfactants can be synthesized via CCTP with a 
target hydrophobic: hydrophilic monomer content. These sur-
factants have been used to stabilize 1.6 hexanediol diacrylate 
emulsions in water with a flow-focusing microfluidic technique 
to produce monodisperse polymer microparticles. The func-
tionalization of the particles was confirmed by using ToF-SIMS 
which demonstrated the presence of key ions on the surface of 
particles compared to microparticles that had been prepared 
without any surfactant. The importance of this surfactant layer 
was shown by the incubation of the polymer microparticles with 
fluorescently labelled P. aeruginosa over 24 h, which showed a 
clear difference in biofilm formation which was dependent on 
particle surface chemistry. This work demonstrates the advanta-
geous use of entrapped surfactants for surface-cell interactions, 
opening new opportunities and applications for 3D biomate-
rials, including wound healing, injectable therapeutics and for 
influencing stem cell differentiation.
4. Experimental Section
Materials: All the materials were used as received unless stated otherwise. 
Ethylene glycol dicyclopentenyl ether acrylate (EGDPEA), 2-hydroxy-3-
phenoxypropyl acrylate (HPhOPA), Poly(ethylene glycol) methacrylate 
with an average Mn of both 360 and 500 (PEGMA360 and PEGMA500) 
and Poly(ethylene glycol) methyl ether methacrylate with an average Mn 
of 164, 300, and 500 (mPEGMA164, mPEGMA300, and mPEGMA500) were 
purchased from Sigma-Aldrich. 2, 2′-azobis (2-methylpropionitrile) (AIBN, 
98%) and 1,6 hexanediol diacrylate (HMDA, 80%) were also obtained 
from Sigma-Aldrich. The catalytic chain transfer agent Bis[(difluoroboryl)
diphenylglyoximato] cobalt (II) (PhCoBF) was supplied from DuPont. The 
cyclohexanone and heptane used as solvents in synthesis and precipitation, 
respectively, were used as received and supplied by Scientific Laboratory 
Supplies and VWR Chemicals, respectively.
Polymer Microarray Production: Slides were prepared by dip-coating 
epoxy-coated glass slides (Genetix) into a 4% (w/v) poly(hydroxyethyl 
methacrylate) solution in ethanol. Slides were left to dry in ambient 
conditions for 24 h. Polymer microarrays were formed using a XYZ3200 
dispensing workstation (Biodot) at 25 °C, 30–40% humidity, and less 
than 0.2% O2 levels. Quilled metal pins (946MP6B, Arrayit) were used 
to transfer monomer solutions (with 1% (w/v) photoinitiator (2,2 
dimethoxy-2-phenylacetonphenone)) onto 20 pHEMA-coated slides 
and irradiated with UV light.[28,29] Microarray slides were allowed to dry 
for a week under vacuum to remove residual solvents and any trace of 
unreacted monomer before bacterial assays.[28]
Bacterial Strains and Growth Conditions: P. aeruginosa strain PAO1 
(Washington sub-line, Nottingham collection) was routinely grown at 
37  °C in lysogeny broth (LB) with shaking at 200  rpm or on LB agar 
(2% w/v). Plasmids for constitutively expressing the fluorescent protein 
mCherry (pMMR)[30] were introduced into the host strain by conjugation.
Polymer Microarray 2D Biological Assay: Before microarrays were 
incubated with P. aeruginosa, the slides were UV sterilized for 10  min. 
After sterilization, slides were placed in 15 mL of RPMI-1640 medium in 
a petri dish which was inoculated (OD600 = 0.01) with mCherry tagged 
P. aeruginosa and left for 24 h at 37 °C at 60 rpm shaking. These conditions 
result in a continuous flow over the surface. After incubation, slides were 
twice washed with phosphate-buffered saline at room temperature for 
5  min and rinsed with distilled water. Fluorescence images were taken 
of both the control slide and bacteria-probed slide using a GenePix 
Autoloader 4200AL (Molecular Devices, US) scanner using a 655–695 nm 
filter. The fluorescence signal from the bacteria attached to polymer spots 
was acquired by subtracting the fluorescence of the control slide from the 
fluorescence of the slide incubated with bacteria, which directly correlates 
with biofilm formation on the polymer surface.
Copolymer Surfactant Synthesis: A typical protocol used for the catalytic 
chain transfer polymerization (CCTP) of both EGDPEA-co-PEGMA360, 
EGDPEA-co-mPEGMA300, and HPhOPA-co-mPEGMA300 copolymers 
was as follows. The appropriate quantities of the monomers required 
to reach the targeted molar ratios (EGDPEA:PEGMA360 2.15  g:0.35  g; 
EGDPEA:PEGMA500/mPEGMA500 2.04g:0.47  g; EGDPEA:mPEGMA300 
2.06  g:0.44  g; HPhOPA:mPEGMA300 2.11  g:0.33  g), were dissolved in 
cyclohexanone in a 1:3 v/v ratio. Initiator and transfer agents were added 
Figure 6. a) Surface coverage by single species (P. aeruginosa) bio-
films quantified after 24 h incubation on particles coated with EGDPEA, 
HPhOPA+EGDPEA, HPhOPA, none, and PVA surfactants respectively in 
RPMI. Quantification was performed on fluorescence images acquired 
from a 48 well-plate considering an area of 568 × 568 µm. Error bars equal 
±  1 SD unit, n = 3. Particle data were normalized for surface area and 
then to the non-surfactant (HMDA) control for comparison. b) Confocal 
microscopy images for mCherry tagged P. aeruginosa growing on each 
polymer surface. Each image is 295 × 295 µm.
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in the reaction vessel with monomers and solvents in the follow order. 
A PhCoBF stock solution of 5  mg mL−1 was prepared in cyclohexanone 
from which aliquot was taken in order to achieve the final concentration 
of 850  ppm (0.89  mg mL−1). Finally, AIBN (0.5%  wt/wt with respect to 
the monomers) was dissolved in cyclohexanone and degassed separately 
prior to being added to the reaction mixture. Finally, the reaction vessel 
and the AIBN solution were degassed purging argon using a standard 
Shlenk line technique for at least 2 h. The temperature adopted during the 
reaction was 75 °C for 18 h. Polymer purification was conducted in excess 
heptane. The usual non-solvent:reaction media ratio was 5:1 v/v in order 
to enhance the precipitation process and, finally, the precipitated materials 
were collected in a vial and left in a vacuum oven for at least 24 h.
NMR spectroscopic analysis was performed on the crude 
polymerization solution to determine polymer conversion and, finally, 
on the precipitate to establish the actual monomer ratio of the final 
copolymer composition.[31] To evaluate the molecular weight of the 
materials, the purified samples were dissolved in HPLC grade THF for 
GPC analysis.
1H-Nuclear Magnetic Resonance Analysis: 1H NMR spectra were 
recorded at 25 °C using a Bruker DPX-300 spectrometer (400  MHz). 
Chemical shifts were recorded in δH (ppm). Samples were dissolved in 
deuterated chloroform (CDCl3) to which chemical shifts are referenced 
(residual chloroform at 7.26 ppm). The 1H NMR spectra of the EGDPEA 
monomer (400 MHz, CDCl3, δH ppm): 6.30 (1H, HCH = CH, dd), 6.03 
(1H, CH2CH,m), 5.70 (1H, HCHCH,dd), 5.45 (1H, dicyclopentenyl 
CHCH, m), 4.14 (2H, OCH2CH2,m), 3.5 (2H,CH2CH2O,m), 3.34 
(1H, OCH(C9H12),m), 2.46–2.29 (m, C7H10), 2.11–1.72 (m, C7H10), 
1.51–1.09 (m, C7H10).
The 1H NMR spectra of the PEGMA monomer (400  MHz, CDCl3, 
δH ppm): 5.81 (1H, HCHCH3, s), 5.27 (1H, HCHCH3, s), 3.97 
(2H, OCH2CH2, m), 3.33 (2H, COOCH2CH2O, and (OCH2CH2O)5, m), 
1.71 (3H, CH2CH3, s).
The 1H NMR spectra of the mPEGMA monomer (400  MHz, CDCl3, 
δH ppm): 5.81 (1H, HCHCH3, s), 5.27 (1H, HCHCH3, s), 3.97 
(2H, OCH2CH2, m), 3.43 (17H, COOCH2CH2O, and (OCH2CH2O)5, m), 
3.14(3H, OCH3, s), 1.71 (3H, CH2 CH3, s).
The 1H NMR spectra of the HPhOPA monomer (400  MHz, CDCl3, 
δH ppm): 7.28–6.91 (5H, C5H5, m), 6.41 (1H, HCHCH3, s), 6.13 (1H, 
HCHCH3, s), 5.86 (1H, HCHH, s), 4.61–3.66 (5H, OCH2HOHCH2O, m).
The 1H NMR of the EGDPEA:PEGMA copolymer purified (400 MHz, 
d-Chloroform, δ, ppm): 5.69–5.47 (2H, CHCH, m), 4.36 (4H, OCH2CH2, 
m), 3.73–3.45 (24H, CH2CH2OCH2, CH2CH2O of both the monomers 
along the ester chain and OCHC9H12, m), 2.51–0.95 (10H, C7H10, m).
The 1H NMR of the EGDPEA: mPEGMA copolymer purified 
(400  MHz, d-Chloroform, δ, ppm): 5.69–5.47 (2H, CHCH, m), 4.36 
(4H, OCH2CH2), 3.73–3.45 (20H, CH2CH2OCH2, CH2CH2O of both the 
monomers along the ester chain and OCHC9H12, m), 3.40 (3H, OCH3, 
m), 2.51-0.95 (10H, C7H10, m).
The 1H-NMR of HPhOPA:mPEGMA copolymer purified 
(400  MHz, d-Chloroform, δ, ppm): 7.22–6.87 (5H, C5H5, m), 4.49-3.71 
(7H, OCH2HOHCH2O, and OCH2CH2, 3.61 (16H, CH2CH2O OCH2CH2O, 
m), 3.40 (3H, OCH3, m),
Gel Permeation Chromatography Analysis: GPC analysis was performed 
by using an Agilent 1260 Infinity instrument equipped with a double 
detector with the light scattering configuration. two mixed columns at 
25 °C were employed, using THF as the mobile phase with a flow rate 
of 1  mL min−1. GPC samples were prepared in HPLC grade THF and 
filtered previous injection. Analysis was carried out using Astra software. 
The number average molecular weight (Mn) and polydispersity (Ð) were 
calculated using PMMA for the calibration curve.
Microfluidic Microparticle Production: Polymer microparticles were 
produced using a 100  µm hydrophilic 3D flow-focusing microfluidic 
droplet generator. Two Havard Instrument syringe pumps were used 
to deliver the continuous and dispersed flows to the microfluidic 
generator. The continuous phase used was distilled water and was set 
at a flow rate of 5 mL h−1. The dispersed phase contained the monomer 
(1,6 hexanediol diacrylate) with 2% w/v polymer surfactant and 
1% w/v photoinitiator (2,2 dimethoxy-2-phenylacetophenone) and 
was set at a flow rate of 0.2 mL h−1. Emulsions were then collected in 
distilled water and irradiated with UV radiation at 365 nm. Particles were 
then characterized for size by using scanning electron microscopy and 
analyzed using ImageJ.
Microparticle Surface Characterisation: Microparticles were placed 
onto a poly(hydroxyethyl) methacrylate substrate and subjected to mass-
spectrometry using a ToF-SIMS IV (IONTOF GmbH, Münster, Germany) 
instrument. 500 µm × 500 µm scans were taken with a Bi3+ primary ion 
source. Data were calibrated and analyzed using IonToF software.
Cell Culture: The human lung fibroblasts MRC-5 (ATCC CCL171, ATCC) 
were cultured in MEM Eagles (Sigma) supplemented with fetal bovine 
serum (10%, Sigma), L-glutamine, non-essential amino acids, penicillin/
streptomycin, and sodium pyruvate (1% each, Sigma). The cells were 
cultured in T75 flasks at 37 °C with 5% supplemental CO2 until 90% 
confluent, before passaging.
Cytotoxicity Assay: After 24 h of the culture period, a two-color 
fluorescence cell viability assay based on simultaneous determination 
of live and dead cells by calcein-AM and ethidium homodimer-1 was 
used. The assay was performed by incubating cells in PBS supplemented 
with 4  µm calcein-AM and 2  µm ethidium homodimer-1 (LIVE/DEAD 
viability/cytotoxicity kit, Invitrogen) at 37 °C for 20  min. After which, 
the cells were washed thrice with fresh PBS and imaged. The emitted 
fluorescent signals of calcein-AM and ethidium homodimer were 
collected at 517 and 615  nm, respectively. Fibroblasts were considered 
viable if the cytoplasm was with calcein-AM (green) and if chromatin 
was not labelled with ethidium homodimer-1 (red).
Bacterial Biofilm Formation: Bacterial attachment and biofilm 
formation on microparticles and flat films were conducted as 
previously described[16] (Huesler et  al.). Briefly, UV-sterilized 48-well 
plates with particles were incubated with RPMI medium (1  mL) 
and inoculated with a P. aeruginosa culture (OD600 of 0.01) for 
24 h at 37  °C and with shaking at 60  rpm. Flat films were prepared 
by UV-polymerising the monomers EGDPEA and HPhOPA with 1% 
w/v photoinitiator (2,2 dimethoxy-2-phenylacetophenone) in an inert 
atmosphere (argon atmosphere <0.2% O2) on glass coverslips. The 
coverslips had previously been activated through a silanization process 
using a solution of 3-(trimethoxysilyl)propyl methacrylate (2% w/v in 
dry toluene at 50 °C in an inert atmosphere for 24 h). Air-dried samples 
were examined using a Carl Zeiss LSM 700 laser scanning confocal 
microscope fitted with 555  nm excitation lasers and a 10×/NA 0.3 
objective. Images were acquired using ZEN 2009 imaging software 
(Carl Zeiss) stacking these optical cross-sections acquired at different 
depths within a sample, a 3D image can be reconstructed. Bacterial 
surface coverage on microparticles was quantified using a MATLAB 
(R2016b) script on the fluorescence images (area size 568 ×  568 µm, 
image resolution 512  ×  512 pixels at 8-bit color depth) taken from 
each well while on flat films with COMSTAT.[32] However, fluorescence 
images representing an area of 295  ×  295  µm with a resolution 
of 1024  ×  1024 pixels at a 12-bit color depth were acquired on the 
microparticles, once transferred onto glass slides, to observe in depth 
the bacterial surface coverage.
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